# Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

> **NCT01028638** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 13 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **OTHER:** 89Zr-bevacizumab PET scan

## Key facts

- **NCT ID:** NCT01028638
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028638, "Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01028638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*